 |
인쇄하기
취소
|
Hanwha Chemical undertakes phase 1 trial for generic Embrel
Hanwha Chemical Co. said it has succeeded in conducting Phase 1 local trials for its generic Embrel with positive results.
The company has a plan to conduct the next clinical trials in cooperation with its affiliated company Dream Pharma, saying the commercialization of its generic product will be made available in 2012.
Enbrel is a prescription medicine that can be self-injected. It is u...
The company has a plan to conduct the next clinical trials in cooperation with its affiliated company Dream Pharma, saying the commercialization of its generic product will be made available in 2012.
Enbrel is a prescription medicine that can be self-injected. It is u...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.